Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoantigen Reactive T Cells in Advanced Gastric Cancer
NCT06432075Phase 1Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Jun 2024
- Primary completion
- Jan 2026
- Modality
- Adoptive Cell Transfer
01
Overview
Phase 1, open-label, single-arm trial of Neoantigen-reactive T cells in gastric cancer (GC), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoint: Number of participants with Adverse Events up to 6 months. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
Neoantigen-reactive T cells
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT06432075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06432075.